US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

97.76

-0.9591-0.97%

Volume:6K

Turnover:566.88K

Market Cap:424.28M

PE:54.51

High:98.00

Open:98.00

Low:97.65

Close:98.72

52wk High:98.82

52wk Low:67.69

Shares:4.34M

Float Shares:4.34M

Volume Ratio:0.24

T/O Rate:0.13%

Dividend:1.55

Dividend Rate:1.58%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.72

PE(LYR):5.24

Loading ...

Overview Company News Filings

Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know

Global Drugmakers Invest Billions to Boost US Presence

Shares of Vertex Pharma up 7.7% Premarket After Rival Genetic Disorder Drug Setback

THOMSON REUTERS

Sionna Scraps Genetic Disorder Drug Program After Trial Setback; Shares Tank

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors

Amgen Inc : HSBC Raises Target Price to $445 from $425

THOMSON REUTERS

Insiders Shake Up General Dynamics, Thermo Fisher, Carvana, Biogen, Charles Schwab

Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million

Canada's DRI Healthcare Q2 Income Rises, Helped by Milestone Events in Royalty Portfolio

Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.

Grail announces FDA advisory committee meeting to review Galleri test PMA

Xenetic Biosciences Q2 Royalty Revenue Rises on Takeda Sublicense

Sino Biopharmaceutical Stock Climbs 3.3% in Hong Kong, Outperforms Competitors

Biogen completes acquisition of RayThera

Biogen Completes Acquisition of RayThera

Biogen Completes Acquisition of Raythera Inc.

THOMSON REUTERS

Halozyme Q2 Revenue Jumps 48%, Raises 2026 Outlook

Vortex Energy Study Confirms Major Salt Structure and New Target at Robinsons River

Biogen Extends Felzartamab Kidney Rejection Trial, Bolstering Long-Term Pipeline Story

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/PBE/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":97.76,"timestamp":1788541313527,"preClose":98.7191,"halted":0,"volume":5794,"delay":0,"changeRate":-0.009715445136756639,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"Trading","change":-0.9591,"latestTime":"09-04 13:07:17 EDT","open":98,"high":98,"low":97.645,"amount":566875.28402,"amplitude":0.003596,"askPrice":97.7,"askSize":100,"bidPrice":97.54,"bidSize":150,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788552000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":98.7191,"sharesOutstanding":3180000,"nav":98.70319,"aum":428371844.6,"dividendRate":0.015823,"bidAskSpread":0.001841,"preHourTrading":{"tag":"盘前","latestPrice":100.7,"preClose":98.7191,"latestTime":"08:08 EDT","volume":2,"amount":199.4191,"timestamp":1788523695710,"change":1.9809,"changeRate":0.020066,"amplitude":0.020066},"postHourTrading":{"tag":"盘后","latestPrice":98.2701,"preClose":98.7191,"latestTime":"19:30 EDT","volume":11,"amount":1085.5828,"timestamp":1788478205255,"change":-0.449,"changeRate":-0.004548,"amplitude":0},"volumeRatio":0.235556,"impliedVol":0.1229,"impliedVolPercentile":0.0198},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4340000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.235556,"shares":4340000,"dividePrice":1.5469,"high":98,"amplitude":0.003596,"preClose":98.7191,"low":97.645,"week52Low":67.69,"pbRate":"1.72","psRate":"247.15","week52High":98.82,"institutionHeld":0.2552,"latestPrice":97.76,"committee":0.2,"eps":1.793292,"divideRate":0.015823,"volume":5794,"delay":0,"ttmEps":1.793292,"open":98,"prevYearClose":82.15,"prevWeekClose":96.32,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":96.32,"twentyDayClose":92.7617,"sixtyDayClose":83.3717},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658713934","title":"Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2658713934","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658713934?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:47","pubTimestamp":1786369636,"startTime":"0","endTime":"0","summary":"• Vertex reported positive Phase 3 data for its non-opioid pain treatment candidate.\n• The company raised its full-year revenue guidance following successful international product launches.\n• Analysts maintain a Buy rating with an average price target of $557.64.","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262092805-market-movers-vrtx-20260810","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","VEGI","VHT","IE000WAW04H5.SGD","CF","IE00BSNM7G36.USD","VRTX","IDNA","LU0098860793.USD","GLAM","PPH","IYH","PBE","LU0114720955.EUR","LU0057025933.USD","LU2433249047.HKD","BK4139","LU0511384066.AUD","IE00BBT3K403.USD","JDOC","RXL","VERX","LU1559883803.SGD","LU1839511570.USD","LU0795875169.SGD","XLV","BBH","ISBC","TRUH","LU1585245621.USD","GNMX","LU0868494708.USD","TBXU","MEDX","AZNH","IBBQ","LU1023059063.AUD","FTXH","FHLC","PJP","IE0004445239.USD","LU0170899867.USD","LU0289739343.SGD","BIB","ABBV","IE000F7OJYX1.SGD","AGNG","LU1934455277.USD","IBB","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931607","title":"Global Drugmakers Invest Billions to Boost US Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931607","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931607?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:16","pubTimestamp":1786367800,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers invest billions to boost US presenceAug 10 (Reuters)-Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470VR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2264538146.SGD","LU0267386448.USD","LU0069063385.USD","LU2746668461.USD","LU1037948541.HKD","CURE","SG9999014567.USD","LU1228905037.USD","AZN","LU2237443465.HKD","LU2746668974.SGD","LU0882574139.USD","LU2471134879.HKD","IE00BK4W5M84.HKD","IE00BVYPNW00.USD","LU0225771236.USD","BK4532","LU2089283258.USD","LU0965509283.SGD","BK4533","LU2896262040.SGD","LU1720051017.SGD","LU0882574055.USD","IE000WAW04H5.SGD","LU0889565916.HKD","LU1941712348.USD","SG9999011175.SGD","SG9999001440.SGD","LU0795875169.SGD","IE00BJJMRZ35.SGD","SG9999014542.SGD","LU0320765489.SGD","BK4504","LU1145028129.USD","LU1221951129.SGD","LU2236285917.USD","OZEM","CANC","LU2271345857.HKD","LU0820562030.AUD","LU0130517989.USD","LU0965509010.AUD","LU2125154778.USD","LU0225284248.USD","LU2403377893.USD","LU0158827948.USD","LU1064131342.USD","LU0912757837.SGD","VHT","LU2168564149.EUR","SG9999014914.USD","IE000MB6IJN5.SGD","LU0320765992.SGD","LU2756315318.SGD","LU1868836757.USD","IE00BFSS8Q28.SGD","MRK","LU0234572021.USD","LU0787776722.HKD","SG9999003800.SGD","LU2552382215.SGD","BMY","LU0792757196.USD","LU1670711040.USD","LU1894683348.USD","LU1929549753.HKD","SGXZ80539844.SGD","BK4568","LU1670627923.USD","IE0001KFT4U8.USD","LU0661504455.SGD","LU2237443382.USD","LU2324357040.USD","LU1829250122.USD","LU2430703095.HKD","BK4566","LU0471298777.SGD","SG9999014575.USD","IE0004445015.USD","LU1043141396.HKD","IE00B4R5TH58.HKD","SG9999015952.SGD","LU0672654240.SGD","SG9999002232.USD","LU1883839398.USD","BK7511","BK4592","LU0211331839.USD","LU1201861249.SGD","LU1267930730.SGD","IE00BWXC8680.SGD","LU0133085943.USD","LU2129689431.USD","IE00BJT1NW94.SGD","SG9999015978.USD","IE00B1XK9C88.USD","LU1571399168.USD","JNJ","LU0310800379.SGD","LU1267930490.SGD","LU2552382132.HKD","LU2505996681.GBP","IE00B19Z3B42.SGD","LU0029864427.USD","LU1983299246.USD","LU0511384066.AUD","IE00B3T34201.USD","LU1127390331.HKD","IE00B894F039.SGD","LU2491050154.USD","SG9999013999.USD","LU0648001328.SGD","LU0097036916.USD","LU1670711123.USD","IE0002141913.USD","LU2347655156.SGD","LU0545562505.USD","LU1506573853.SGD","LLYZ","LLII","LU1232071149.USD","ELIL","LU0861579265.USD","LU1037948897.HKD","LU1718418525.SGD","LU2168564065.EUR","GB00BDT5M118.USD","LU1066051811.HKD","PFE","FHLC","LU0289739699.SGD","LU0128525929.USD","LU0211328371.USD","LU0417517546.SGD","LU1093756168.USD","LU1712237335.SGD","BIB","LU2750360641.GBP","LU2750360997.AUD","LU0820561909.HKD","LU0061475181.USD","IBBQ","LU1244550221.USD","LU1974910355.USD","LU2023250843.SGD","IE00BGHQF631.EUR","LU1116320901.HKD","WDNA","IYH","LLYX","LU2133065610.SGD","BK4139","LU1732800096.USD","SG9999018865.SGD","LU0738911758.USD","SG9999015358.SGD","BMED","SG9999001176.USD","LU2125909247.SGD","LU0124676726.USD","LU0079474960.USD","LU0306806265.USD","LU0786609619.USD","LU0256863902.USD","SGXZ51526630.SGD","SG9999014880.SGD","LU1066051498.USD","SG9999015986.USD","LU1244550577.SGD","LU0320765646.SGD","LU2361045086.USD","IE00BJJMRX11.SGD","LU0426412945.USD","IE00BLSP4452.SGD","LU1804176565.USD","SGXZ81514606.USD","IE000SO60NU8.SGD","LU0210536198.USD","LU2112291526.USD","LU0965508806.USD","LU2491049909.HKD","MEDI","LU2237443622.USD","SGXZ57979304.SGD","LU1162221912.USD","BK4534","BK4599","IE000BZT7R73.USD","LU0385154629.USD","HRTS","LU0256863811.USD","LU0795875086.SGD","LU2361044865.SGD","IE0009355771.USD","LU2111349929.HKD","LU2265009873.SGD","LU0323591593.USD","LU0964807845.USD","LU1868836914.USD","LU2461242641.AUD","LU1988902786.USD","PJP","LU1121112475.USD","LU2491050071.SGD","IE0002270589.USD","LU0345769631.USD","IE00BVYPNV92.GBP","LU1267930573.SGD","IE0005OL40V9.USD","LU2023251221.USD","IE00BFTCPJ56.SGD","LU2471134523.USD","SG9999014898.SGD","BK4007","LU0726765562.USD","LU0203345920.USD","LU1839511570.USD","IE00BFSS7M15.SGD","LU0466842654.USD","LU2237443978.SGD","LU2211815571.USD","IE00BFXG1179.USD","LU2125909593.SGD","LU2456880835.USD","LU0106261372.USD","LU1323610961.USD","IE00B7KXQ091.USD","LU1069344957.HKD","LU2237443895.HKD","CSL.AU","JDOC","LU0162691827.USD","LU0553294199.USD","BK4550","LU2360032135.SGD","LU1043141123.HKD","IE00B19Z3581.USD","LU0985481810.HKD","IE00BJJMRY28.SGD","LU0170899867.USD","LU0210528500.USD","LU0094547139.USD","IE00BK4W5L77.USD","LU0823434583.USD","LU1868837300.USD","ELIS","ILDR","LU0708994859.HKD","LU0820561818.USD","LU0266013472.USD","LU1935042991.SGD","LU1989772840.SGD","LU0237698245.USD","LU0320765059.SGD","LU0689626769.HKD","IE00BDGV0183.EUR","LU2462157665.USD","LU0310799852.SGD","LU0198837287.USD","LU0174119429.USD","BK7508","LU2347655073.USD","IE00BKDWB100.SGD","IE0034235303.USD","LU0472753341.HKD","LU1551013425.SGD","LU0432979614.USD","BK4583","LU0889566641.SGD","IE00B2B36J28.USD","LU1228905540.USD","BK4578","IE0004445239.USD","LU1914381329.SGD","LU1989772923.USD","LU0072461881.USD","LU0943347566.SGD","FTXH","IE00B3PB1722.GBP","LU1868837136.USD","LU0689472784.USD","LU0994945656.USD","LU0070302665.USD","LU0965509101.SGD","LU0006306889.USD","LU2487616109.SGD","AZNH","LU0868494617.USD","IE00BN8TJ469.HKD","SGXZ99366536.SGD","LU1699723380.USD","LU0683600562.USD","LU1496350171.SGD","IE00BKVL7J92.USD","LU1670628061.USD","AGNG","LU2471134952.CNY","LU1934455194.USD","LU2237438978.USD","LU2357627491.SGD","LU2430703251.USD","TMED","LU0859254822.USD","AMGN","LU1032955483.USD","LU2106854487.HKD","LU0070217475.USD","LU2089284900.SGD","LU1003077747.HKD","LU1032466523.USD","BK4588","LU2468319806.SGD","LU0426417589.USD","LU2592432038.USD","LU0316494557.USD","BBH","LU0985320562.USD","LU1430594728.SGD","IE00B19Z9Z06.USD","BK4585","LU0225283273.USD","LU1066053197.SGD","LU1814569148.SGD","LU0109391861.USD","LU2471134796.USD","LU0353189680.USD","LU1074936037.SGD","BK7501","LU1674673428.USD","LU2360106947.USD","LU1732799900.SGD","LU1116320737.USD","LU0158827781.USD","LU0208291251.USD","LU0130102774.USD","LU0345770308.USD","LU1057294990.SGD","LU2242646821.SGD","LU0354030511.USD","LU0708995401.HKD","LU1221951046.USD","IE00BZ1G4Q59.USD","THNR","LU0980610538.SGD","GSKH","LU1720051108.HKD","LU1035775433.USD","LU2433249047.HKD","LU0057025933.USD","GSK","BIIB","LU2242652126.USD","IE00B4JS1V06.HKD","LU0203347892.USD","LU1989771016.USD","LU1059921491.USD","LU1941712264.USD","LU2430703178.SGD","GDOC","LU0096364046.USD","04332","LU1267930813.SGD","LU0234570918.USD","LU2168564222.USD","SG9999002224.SGD","LU1629891620.HKD","LU1196500208.SGD","LU1548497426.USD","IE00B775H168.HKD","LU1280957306.USD","BK4559","LU0354030438.USD","MHIP","LU0058720904.USD","LU2505996509.AUD","IE00BSNM7G36.USD","LU2129689514.USD","LU2596442595.SGD","LU1585245621.USD","IE00B7SZLL34.SGD","IE000F7OJYX1.SGD","SG9999018857.SGD","BK4516","LU2087625088.SGD","LU0211327993.USD","LU0345770993.USD","LU2089984988.USD","LU1035773651.USD","LU1923622614.USD","LU0640476718.USD","IE00BKPKM429.USD","IE000M9KFDE8.USD","TBXU","LU2602419157.SGD","SG9999015945.SGD","LU2361044949.HKD","LU0265550359.USD","LLY","LU2023250504.SGD","LU1261432733.SGD","LU0053666078.USD","LU2357305700.SGD","LU0203202063.USD","PPH","LU1551013342.USD","LU2108987350.USD","ABBV","LU1778281490.HKD","GLAM","LU0289961442.SGD","LU1496350502.SGD","IE00B1BXHZ80.USD","LU1623119135.USD","BK7067","LU0471298694.HKD","LU0949170772.SGD","LU0321505439.SGD","LU0345769128.USD","LU0265550946.USD","LU1868836591.USD","LU1934455277.USD","LU2168564495.EUR","PBE","LU0545039389.USD","LU1934455863.HKD","GILD","IXJ","XLV","LU2213496289.HKD","LU0942090050.USD","LU1023059063.AUD","LU1366192091.USD","RXL","TRUH","IE00B19Z9P08.USD","LU0203201768.USD","LU0823416689.USD","LU2087621335.USD","LU2237443549.SGD","LU1093756325.SGD","LU0098860793.USD","LU1674673691.USD","LU2063271972.USD","IE00B42XCP33.USD","LU0353189763.USD","LU2129689605.HKD","SG9999001176.SGD","LU2028103732.USD","LU1244550494.USD","LU1894683264.USD","BK4581","SG9999014559.SGD","LU2552382058.USD","SGXZ31699556.SGD","LU0477156953.USD","LU1066051225.USD","LU1670710661.SGD","LU1291159041.SGD","LU1061106388.HKD","IE00BLSP4239.USD","LU0122379950.USD","LU1917777945.USD","LU2462591350.SGD","PAWZ","SG9999017495.SGD","MEDX","LU0823434740.USD","LU0289739343.SGD","IE00BJLML261.HKD","IE00BBT3K403.USD","LU0306807586.USD","SG9999015341.SGD","IE00BN29S564.USD","SG9999014906.USD","IBB","LU0868494708.USD","LU0456855351.SGD","LU0395794307.EUR","LU1979441026.SGD","LU2756315664.SGD","LU2023250330.USD","LU0321505868.SGD","GSK.UK","LU0238689110.USD","LU1069347547.HKD","LU0109394709.USD","IHE","LU0114720955.EUR","LU2125154935.USD","LU1670710588.SGD","LU2417539215.USD","LU2168563687.JPY","IE0000B7K699.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658396419","title":"Shares of Vertex Pharma up 7.7% Premarket After Rival Genetic Disorder Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2658396419","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658396419?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:47","pubTimestamp":1786366034,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470WN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B2B36J28.USD","LU0079474960.USD","LU1093756325.SGD","LU2468319806.SGD","TBXU","BK4139","LU2236285917.USD","LU0289739699.SGD","IE0002270589.USD","BIB","IE0009355771.USD","BK4585","IE00B19Z3B42.SGD","BK4532","IBBQ","IE00B19Z9Z06.USD","GNMX","IDNA","IE00BFTCPJ56.SGD","BBH","LU0256863811.USD","LU2456880835.USD","LU0432979614.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU0058720904.USD","LU0889565916.HKD","IE00B19Z3581.USD","SG9999013999.USD","VRTX","IE00BJT1NW94.SGD","LU2417539215.USD","SGXZ57979304.SGD","LU1035775433.USD","LU2362541513.USD","LU2237438978.USD","PBE","IBB","LU0320765992.SGD","LU1430594728.SGD","LU0417517546.SGD","LU1585245621.USD","IE0002141913.USD","LU1778281490.HKD","LU2324357040.USD","IE00BZ9MQY76.HKD","LU2362540622.SGD","LU2362541273.HKD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658270935","title":"Sionna Scraps Genetic Disorder Drug Program After Trial Setback; Shares Tank","url":"https://stock-news.laohu8.com/highlight/detail?id=2658270935","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658270935?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:03","pubTimestamp":1786363413,"startTime":"0","endTime":"0","summary":"Sionna scraps genetic disorder drug program after trial setback; shares tankAug 10 (Reuters)-Sionna TherapeuticsSION.Osaid on Monday it would stop developing its experimental drug as an addition to st","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470O4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0009355771.USD","LU2456880835.USD","LU0061475181.USD","LU2362541273.HKD","IE00B19Z3B42.SGD","VRTX","BK4585","LU1585245621.USD","LU2417539215.USD","PBE","LU0417517546.SGD","LU2362541513.USD","IE00B19Z3581.USD","BK4567","BBH","BK4532","BIB","GNMX","IE00B4R5TH58.HKD","LU1069344957.HKD","BK4588","TBXU","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0823416689.USD","IBBQ","LU2324357040.USD","IE00B19Z9P08.USD","LU1674673691.USD","IE00B19Z9Z06.USD","SG9999001176.SGD","SION","LU0058720904.USD","IE00BJT1NW94.SGD","LU2236285917.USD","LU2362540622.SGD","SG9999013999.USD","SGXZ57979304.SGD","LU1035775433.USD","LU1674673428.USD","BK4533","IE00B894F039.SGD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU0320765992.SGD","IBB","IDNA","LU0256863811.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658936984","title":"Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:","url":"https://stock-news.laohu8.com/highlight/detail?id=2658936984","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658936984?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":"Major Regulatory Milestone Positions Company to Initiate Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Patented First-in-Class Neuroprotective Therapy Targeting Demyelination Lucid-MS ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/10/3341697/0/en/quantum-biopharma-receives-united-states-fda-clearance-to-proceed-with-lucid-ms-phase-2-trial-in-progressive-multiple-sclerosis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B775H168.HKD","LU0053666078.USD","LU2089284900.SGD","KBWB","LCDL","KBWP","BK4596","LU1035773651.USD","NBIX","LU0912757837.SGD","IE0005OL40V9.USD","PGR","BIIB","IE0004445015.USD","LU0731783394.SGD","LABU","BK4532","IND","LXRX","LCID","BMED","BNDI","QNTM","LU1718418525.SGD","IE00BZ1G4Q59.USD","BK4516","LU1988902786.USD","CAGR","LU0320765992.SGD","UBCP","LU2087625088.SGD","LU1481011671.HKD","LCIZ","IE00BN29S564.USD","LU0772969993.USD","BK4139","BK4007","IAK","LU0889565916.HKD","LU1244550221.USD","LU1366192091.USD","PBE","BK4099","LU0070302665.USD","LU2065170008.USD","LU0971096721.USD","BK4504","LU1668664300.SGD","NVIB","IAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658891989","title":"Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658891989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658891989?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:33","pubTimestamp":1786350780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 0.9% to 5.05 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.0% to 25937.49.The stock's fall snapped a two-day winning streak.Sino Biopharmaceutical Ltd. closed 45% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.7% and Amgen Inc. remained unchanged.Trading volume totaled 86.6 million shares, compared to the 50-day average of 101.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","BK1191","BK1521","01177","LU0058720904.USD","LU1061106388.HKD","BK4599","IE00BJT1NW94.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","BK1515","IE00BJJMRZ35.SGD","LU1023059063.AUD","PJP","IE0009355771.USD","TBXU","BK4534","LU0122379950.USD","HK0000165453.HKD","LU0889565916.HKD","LU2112291526.USD","LU2242652126.USD","IBBQ","LU0289739699.SGD","BK4588","BK4585","LU2242646821.SGD","BK4581","LU1057294990.SGD","BIB","BBH","BK1589","IBB","AMGN","LU0320765992.SGD","LU1983299246.USD","LU2089984988.USD","BK4139","BK4566","IE00B2B36J28.USD","LU0109394709.USD","LU1571399168.USD","SG9999001440.SGD","IE00BZ08YT58.USD","IE00B4R5TH58.HKD","IE00BZ08YS42.EUR","BK4533","LU2468319806.SGD","LU0868494617.USD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658042600","title":"Amgen Inc : HSBC Raises Target Price to $445 from $425","url":"https://stock-news.laohu8.com/highlight/detail?id=2658042600","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658042600?lang=en_us&edition=fundamental","pubTime":"2026-08-10 14:30","pubTimestamp":1786343453,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN44709K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFTCPJ56.SGD","BK4533","LU0109394709.USD","TBXU","LU2468319806.SGD","PJP","BK4139","LU2089984988.USD","IE0002141913.USD","IBB","IE00B2B36J28.USD","BK4566","LU1061106388.HKD","LU2242646821.SGD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU1983299246.USD","LU1571399168.USD","LU1057294990.SGD","BK4585","LU0289739699.SGD","LU0889565916.HKD","BBH","LU1023059063.AUD","BK4534","IE0009355771.USD","BK4588","AMGN","BIB","IE00BJT1NW94.SGD","LU0320765992.SGD","SG9999001440.SGD","IBBQ","PBE","IE00B4R5TH58.HKD","BK4599","LU2112291526.USD","BK4581","LU2242652126.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657678830","title":"Insiders Shake Up General Dynamics, Thermo Fisher, Carvana, Biogen, Charles Schwab","url":"https://stock-news.laohu8.com/highlight/detail?id=2657678830","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657678830?lang=en_us&edition=fundamental","pubTime":"2026-08-08 21:01","pubTimestamp":1786194074,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($GD)), (($TMO)), (($CVNA)), (($BIIB)) and (($SCHW)). Here is a breakdown of their recent trades and th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/insiders-shake-up-general-dynamics-thermo-fisher-carvana-biogen-charles-schwab?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/insiders-shake-up-general-dynamics-thermo-fisher-carvana-biogen-charles-schwab?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLIX","LU0477156953.USD","LU0133085943.USD","BK4139","SG9999001077.SGD","LU0251131958.USD","LU1861217088.USD","LU1791807156.HKD","BK4548","LU0128525929.USD","LU0648001328.SGD","LU1861220207.SGD","BK4503","BK4127","BK4589","LU0742534661.SGD","CVNA","BK4532","LU0889565916.HKD","LU0029864427.USD","LU0345774391.USD","LU0971096721.USD","LU2360107671.USD","CVNX","BK4588","BMED","LU0708994859.HKD","LU1668664300.SGD","LU1868837136.USD","SG9999014021.USD","LU0640476718.USD","LU1267930573.SGD","SCHW","LU0320765992.SGD","LU0266013472.USD","IE00B894F039.SGD","IE00B19Z3B42.SGD","PBE","CVNY","IAI","LU1363072403.SGD","IE00BD6J9T35.USD","LU0011850046.USD","IE00B19Z9P08.USD","LU0251142724.SGD","LU0130517989.USD","IE0002270589.USD","LU0175139822.USD","BIIB","LU1868836914.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657402621","title":"Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657402621","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657402621?lang=en_us&edition=fundamental","pubTime":"2026-08-08 06:46","pubTimestamp":1786142807,"startTime":"0","endTime":"0","summary":"Amgen SVP, Chief Compliance Officer Nancy Grygiel sells 2,970 shares for $1.2 millionAmgen SVP and chief compliance officer Nancy A. Grygiel exercised stock options on Aug. 6, 2026, acquiring 2,970 co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL4RnJzY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU1023059063.AUD","BK4534","IE0002141913.USD","LU1571399168.USD","LU1061106388.HKD","LU2112291526.USD","LU0889565916.HKD","BK4585","LU0289739699.SGD","LU1057294990.SGD","LU2089984988.USD","IE00BJT1NW94.SGD","LU2242652126.USD","BBH","LU0109394709.USD","LU0122379950.USD","SG9999001440.SGD","LU0320765992.SGD","LU1983299246.USD","PBE","LU2242646821.SGD","IBBQ","BK4139","IE00BFTCPJ56.SGD","BK4588","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU0868494617.USD","AMGN","IE0009355771.USD","BIB","BK4533","LU0058720904.USD","IE00B4R5TH58.HKD","BK4581","PJP","BK4566","BK4599","IBB","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657629107","title":"Canada's DRI Healthcare Q2 Income Rises, Helped by Milestone Events in Royalty Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2657629107","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657629107?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:12","pubTimestamp":1786137124,"startTime":"0","endTime":"0","summary":"Canada's DRI Healthcare Q2 income rises, helped by milestone events in royalty portfolioOverviewCanada pharmaceutical royalty investor's Q2 total income rose to a record $50.1 mlnAdjusted EBITDA margi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL1N444109:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","RPRX","LGND","LU0566484027.USD","PBE","HELX","XNCR","BK4007","BK4139","LU1559883803.SGD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657469640","title":"Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.","url":"https://stock-news.laohu8.com/highlight/detail?id=2657469640","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657469640?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:36","pubTimestamp":1786120560,"startTime":"0","endTime":"0","summary":"Replimune Group received Food and Drug Administration clearance for its experimental skin cancer drug, concluding a saga that saw regulators twice deny its application. The stock was falling anyway.Th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","BK4534","LU2468319806.SGD","PJP","LU1868836591.USD","LU1983299246.USD","TBXU","LU1093756168.USD","BK4007","IOVA","IE00BSNM7G36.USD","LU1670711123.USD","IHE","LU1868837136.USD","BK4533","BK4532","LU1061106388.HKD","LU1585245621.USD","LU1989771016.USD","PBE","REPL","AMGN","LU1323610961.USD","SG9999001440.SGD","BIB","LU0225284248.USD","LU0868494617.USD","FTXH","LU0321505868.SGD","LU2242646821.SGD","LU0114720955.EUR","BMY","LU0985481810.HKD","IBB","IE0002141913.USD","LU1718418525.SGD","LABU","LU0306806265.USD","IBBQ","BBH","LU0306807586.USD","LU1883839398.USD","LU0237698245.USD","LU0061475181.USD","LU1023059063.AUD","LU0289739699.SGD","LU1093756325.SGD","LU2089984988.USD","BK4585","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642727","title":"Grail announces FDA advisory committee meeting to review Galleri test PMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642727","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642727?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:10","pubTimestamp":1786115445,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","IBRN","BK4129","BBP","BK4139","BK4588","FBT","SBIO","GRAL","BBH","LABU","PMA","PBE","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657645729","title":"Xenetic Biosciences Q2 Royalty Revenue Rises on Takeda Sublicense","url":"https://stock-news.laohu8.com/highlight/detail?id=2657645729","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657645729?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:44","pubTimestamp":1786106668,"startTime":"0","endTime":"0","summary":"Xenetic Biosciences Q2 royalty revenue rises on Takeda sublicenseOverviewUS biopharma firm's Q2 royalty revenue rose 12% yr/yr, driven by Takeda sublicenseQ2 net loss widened to $0.9 mln from $0.7 mln","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL1N4440HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","BK4007","XNCR","RPRX","AGEN","XBIO","BK4139","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657615971","title":"Sino Biopharmaceutical Stock Climbs 3.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2657615971","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657615971?lang=en_us&edition=fundamental","pubTime":"2026-08-07 16:30","pubTimestamp":1786091400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 3.3% to 5.10 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 25668.03.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 44% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 2.2% and Amgen Inc. remained unchanged.Trading volume totaled 88.6 million shares, compared to the 50-day average of 101.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU2242646821.SGD","BK4588","HK0000165453.HKD","BBH","PJP","LU2242652126.USD","LU0868494617.USD","BK4566","IBB","IE00B2B36J28.USD","LU0122379950.USD","BK4533","BK4139","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE0002141913.USD","IE00BZ08YR35.GBP","LU1571399168.USD","BK4585","BK1191","LU2089984988.USD","BK1521","AMGN","TBXU","IE00BJJMRZ35.SGD","BK4534","PBE","LU1061106388.HKD","BIB","IE00BZ08YS42.EUR","BK1515","LU0889565916.HKD","IE0009355771.USD","LU1023059063.AUD","LU1057294990.SGD","BK1589","IBBQ","LU2112291526.USD","BK4599","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU0289739699.SGD","LU1983299246.USD","IE00BZ08YT58.USD","LU0058720904.USD","SG9999001440.SGD","01177","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657050661","title":"Biogen completes acquisition of RayThera","url":"https://stock-news.laohu8.com/highlight/detail?id=2657050661","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657050661?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:55","pubTimestamp":1786056934,"startTime":"0","endTime":"0","summary":"Biogen (BIIB) announced the completion of the acquisition of RayThera Inc., a privately held biotechnology company focused on discovering and devel...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biogen-completes-acquisition-of-raythera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biogen-completes-acquisition-of-raythera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4588","AGNG","IE00B19Z9P08.USD","IBB","XT","BK4533","BIIB","BK4139","JDOC","BK4585","BMED","IE00B19Z9Z06.USD","BBP","LNGR","FHLC","PBE","DARP","LU0889565916.HKD","RSPH","IEIH","LU0234570918.USD","FWD","LU0320765992.SGD","IE00B894F039.SGD","LU0109394709.USD","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657166970","title":"Biogen Completes Acquisition of RayThera","url":"https://stock-news.laohu8.com/highlight/detail?id=2657166970","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657166970?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:33","pubTimestamp":1786055631,"startTime":"0","endTime":"0","summary":"Biogen completes acquisition of RayTheraBiogen completed its acquisition of privately held RayThera, adding small-molecule immunology programs to its pipeline.The deal expands Biogen’s immunology port","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDLjzXq7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU0320765992.SGD","LU0109394709.USD","BK4588","LU2095319765.USD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU0234570918.USD","BK4533","IE00B19Z9P08.USD","LU2210150020.SGD","BIIB","BK4585","IE00B894F039.SGD","SG9999014021.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","BCDF","BK4112","IE00BGHQF748.EUR","SG9999014005.SGD","NDAQ","LU0314104364.USD","LU0889565916.HKD","IE00B19Z9Z06.USD","SG9999014039.USD","BK4532","BMED","IE00BN0W2V16.EUR","PBE","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657699536","title":"Biogen Completes Acquisition of Raythera Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2657699536","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657699536?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:15","pubTimestamp":1786054500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUA9DNYGT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","LU0234570918.USD","LU0109394709.USD","BK4533","BK4139","IE00B19Z9Z06.USD","LU0889565916.HKD","PBE","BK4585","IE00B19Z9P08.USD","IE00B894F039.SGD","BK4588","BIIB","LU0320765992.SGD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657657085","title":"Halozyme Q2 Revenue Jumps 48%, Raises 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657657085","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657657085?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:11","pubTimestamp":1786047072,"startTime":"0","endTime":"0","summary":"Halozyme Q2 revenue jumps 48%, raises 2026 outlookOverviewU.S. biopharma firm's Q2 revenue rose 48% yr/yr, beating analyst expectationsAdjusted EPS for Q2 beat analyst expectationsCompany raised 2026 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431CZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FFOX","IHE","BK4007","HALO","KYMR","LGND","IE0009354923.USD","PBE","HELX","LU0566484027.USD","LU1559883803.SGD","RPRX","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567836","title":"Vortex Energy Study Confirms Major Salt Structure and New Target at Robinsons River","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567836","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567836?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:59","pubTimestamp":1786035577,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) just unveiled an announcement. Vortex Energy Corp. reported final results from a technical study by Lonquist Fi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-study-confirms-major-salt-structure-and-new-target-at-robinsons-river?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-study-confirms-major-salt-structure-and-new-target-at-robinsons-river?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2417539215.USD","IE00BJT1NW94.SGD","SG9999001176.SGD","SG9999013999.USD","LU1585245621.USD","BK4588","LU2468319806.SGD","IE00BJJMRZ35.SGD","BK4585","BK4567","LU1069344957.HKD","LU0417517546.SGD","LU2236285917.USD","SG9999001176.USD","LU1093756168.USD","BBH","LU2324357040.USD","GNMX","IE00B4R5TH58.HKD","BIB","LU1674673428.USD","LU2362540622.SGD","LU2462157665.USD","TBXU","BK4532","IBB","IDNA","IE00B19Z3B42.SGD","LU2362541273.HKD","LU2089984988.USD","SGXZ57979304.SGD","IE00BZ9MQY76.HKD","LU0289739699.SGD","LU1430594728.SGD","LU1778281490.HKD","VRTX","LU2362541513.USD","BK4139","LU0109394709.USD","IE0002141913.USD","IE00B894F039.SGD","LU1035775433.USD","LU0061475181.USD","LU0889565916.HKD","IE0009355771.USD","LU0256863811.USD","IBBQ","PBE","LU2237438978.USD","LU2456880835.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656902","title":"Biogen Extends Felzartamab Kidney Rejection Trial, Bolstering Long-Term Pipeline Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656902","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656902?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:41","pubTimestamp":1786034492,"startTime":"0","endTime":"0","summary":"Biogen Inc. ($BIIB) announced an update on their ongoing clinical study. Biogen extends study of kidney rejection drug felzartamab This long-term e...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biogen-extends-felzartamab-kidney-rejection-trial-bolstering-long-term-pipeline-story?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biogen-extends-felzartamab-kidney-rejection-trial-bolstering-long-term-pipeline-story?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","BIIB","BK4585","BK4139","LU0320765992.SGD","BMED","PBE","BK4532","IE00B19Z9P08.USD","BK4588","IE00B19Z9Z06.USD","IE00B894F039.SGD","LU0889565916.HKD","LU0234570918.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}